HCV
Clinical trials for HCV explained in plain language.
Never miss a new study
Get alerted when new HCV trials appear
Sign up with your email to follow new studies for HCV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
French cities launch community push to wipe out hepatitis c in drug users
Disease control OngoingThis study aims to eliminate hepatitis C among people who use drugs in Paris, Marseille, Lyon, and Fort-de-France. Researchers will screen participants, provide immediate treatment, and use a peer-referral system to reach more people. The goal is to see if this community-based ap…
Matched conditions: HCV
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
Prevention OngoingThis pilot trial tests whether training Gancheros—people who provide injection services in exchange for money or drugs—can lower HIV, hepatitis C, and overdose risks among migrant Puerto Rican people who inject drugs in New York City. Gancheros will attend six sessions on prevent…
Matched conditions: HCV
Phase: NA • Sponsor: North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
One-Stop care may boost HIV and hep c treatment in drug users
Prevention OngoingThis study tests whether providing HIV prevention (PrEP) and hepatitis C treatment together at one location works better than sending patients to separate clinics. About 446 people who inject drugs will be randomly assigned to either on-site integrated care or off-site referrals …
Matched conditions: HCV
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC